BioSpace News Archive

Business

MoonLake Immunotherapeutics appoints former Kymab CEO Simon Sturge as Chairman and Spike Loy to the Board of Directors

MoonLake Immunotherapeutics AG today announced the appointment of Mr. Sturge as Chairman.

August 10, 2021
·
3 min read
Business

iSpecimen Reports Second Quarter 2021 Financial Results

iSpecimen Inc. today reported its financial results for the three-month period ended June 30, 2021.

August 10, 2021
·
12 min read
Business

Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results

Anticipate initiating a Phase 3 trial of adjunctive ganaxolone in tuberous sclerosis complex (TSC) in Q3 2021, targeting first patient enrolled during Q4 2021; continue to expect topline Phase 2, open label data in Q3 2021

August 10, 2021
·
15 min read
Deals

Visus Therapeutics Secures $20 Million in Additional Financing Led by New Investor LSP, with Participation from Sage Partners

Proceeds will support clinical and commercial efforts for lead asset BRIMOCHOL™ under investigation for presbyopia as well as new research and development activities in the Company’s drug development pipeline

August 10, 2021
·
4 min read
Deals

Nanox Enters into Acquisition via Merger Agreement with Zebra Medical Vision Ltd. and Announces Entry into Binding Letter of Intent with USARAD Holdings Inc.

Upon the consummation of the acquisition, Nanox and Zebra Medical Vision anticipate that their mutual goal of global scanning to protect one’s health will put them in the position to potentially become the next generation AI-enabled medical device leader.

August 10, 2021
·
13 min read
Biotech Beach

Aurora Spine Corporation Announces First Patients in Multicenter Study of ZIP® Interspinous Fixation Device

Aurora Spine Corporation today announced that the first patients have been enrolled into a pivotal multi-center study of its ZIP® Interspinous Fixation device for patients suffering from back pain due to symptomatic degenerative disc disease.

August 10, 2021
·
4 min read
Business

Abeona Therapeutics Appoints Edward Carr as Chief Financial Officer

Abeona Therapeutics Inc. today announced the appointment of Edward Carr as Chief Financial Officer and Principal Financial Officer, effective immediately.

August 10, 2021
·
3 min read
Business

Verrica Pharmaceuticals Reports Second Quarter 2021 Financial Results

Verrica Pharmaceuticals Inc. today announced financial results for the second quarter ended June 30, 2021.

August 10, 2021
·
12 min read
Drug Development

InflaRx Announces Positive Data from Second Interim Analysis of Ongoing Phase IIa Open Label Study with Vilobelimab in Pyoderma Gangraenosum

InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announces positive data from the first 10 evaluable patients in the ongoing Phase IIa open label study with vilobelimab in Pyoderma Gangraenosum (PG).

August 10, 2021
·
7 min read
Business

Kaleido Biosciences and the COPD Foundation Announce a Strategic Collaboration to Advance KB109 into Phase 2 Clinical TrialOn track to initiate Phase 2 trial in the first quarter of 2022

Kaleido Biosciences, Inc. today announced a strategic collaboration with the COPD Foundation to study KB109 in patients with chronic obstructive pulmonary disease (COPD).

August 10, 2021
·
7 min read